期刊文献+

Clinical Study of Qingluo Tongbi Granules in Treating 63 Patients with Rheumatoid Arthritis of the Type of Yin-deficiency and Heat in Collaterals 被引量:2

Clinical Study of Qingluo Tongbi Granules in Treating 63 Patients with Rheumatoid Arthritis of the Type of Yin-deficiency and Heat in Collaterals
暂未订购
导出
摘要 The study is to observe the therapeutic effects of Qingluo Tongbi Granules (清络通痹颗粒QTG) in patients with rheumatoid arthritis (RA) and the changes of immune indexes. In this series there are 63 patients with RA of the type of yin-deficiency and heat in collaterals treated with QTG as the treated group and 55 patients of the same type treated with Tripterygium glycosides as the control group. As a results, in the treated group, the curative rate is 9.52% and markedly effective rate 38.10%, with a total effective rate of 90.48%, while the corresponding rates in the control group are 0, 20.00% and 83.64%, respectively. The curative effect in the treated group is better than that in the control group (P<0.05). Besides, no obvious adverse reactions are found in the treated group. Therefore it is concluded that as a new medicinal preparation QTG is safe and effective in the treatment of RA. The study is to observe the therapeutic effects of Qingluo Tongbi Granules(清络通痹颗粒 QTG)in patients with rheumatoid arthritis(RA)and the changes of immune indexes.In this series there are 63 patients with RA of the type of yin-deficiency and heat in collaterals treated with QTG as the treated group and 55 patients of the same type treated with Tripterygium glycosides as the control group.As a results,in the treated group,the curative rate is 9.52% and markedly effective rate 38.10%,with a total effective rate of 90.48%,while the corresponding rates in the control group are 0,20.00% and 83.64%,respectively.The curative effect in the treated group is better than that in the control group(P<0.05).Besides,no obvious adverse reactions are found in the treated group.Therefore it is concluded that as a new medicinal preparation QTG is safe and effective in the treatment of RA.
出处 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2004年第2期83-87,共5页 中医杂志(英文版)
  • 相关文献

参考文献3

二级参考文献7

  • 1Pan R Y,Arthritis Rheum,2000年,43卷,289页
  • 2Kim K N,J Immunol,2000年,164卷,1576页
  • 3Takayanagi H,J Clin Invest,1999年,104卷,137页
  • 4Ma Y,J Immunol,1998年,161卷,1516页
  • 5Le C H,Arthritis Rheum,1997年,40卷,1662页
  • 6Zhang H,J Clin Invest,1997年,100卷,1951页
  • 7卢圣栋,现代分子生物学实验技术,1993年,241页

共引文献37

同被引文献62

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部